Clearside Biomedical Inc (FRA:CLM)
€ 0.885 0.065 (7.93%) Market Cap: 69.14 Mil Enterprise Value: 47.25 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Q3 2023 Clearside Biomedical Inc Earnings Call Transcript

Nov 13, 2023 / 09:30PM GMT
Operator

Greetings, and welcome to the Clearside Biomedical third quarter 2023 financial results and corporate update call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Jenny Corbin of Clearside Investor Relations. Ma'am, the floor is yours.

Jenny Kobin
Investor Relations Advisory Solutions - IR

Good afternoon, everyone, and thank you for joining us on the call today. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2022, our quarterly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot